Association between clinical activity and high-resolution tomography findings in pulmonary wegener's granulomatosis

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 6, 2008, Pages 833-838

  Zycinska, K ^a   Wardyn, K A ^a   Zycinski, Z ^a   Zielonka, T M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Pulmonary involvement; Wegener's granulomatosis

Indexed keywords

ADULT; ARTICLE; BRONCHOSCOPY; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FUNCTION TEST; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PLEURA; THORAX RADIOGRAPHY; WEGENER GRANULOMATOSIS; BLOOD; BLOOD CELL COUNT; COMPUTER ASSISTED TOMOGRAPHY; LUNG DISEASE; METABOLISM; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

C REACTIVE PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BLOOD CELL COUNT; BRONCHOSCOPY; C-REACTIVE PROTEIN; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; WEGENER GRANULOMATOSIS;

EID: 64549130398     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-498.
2. Zycińska K, Wardyn KA, Zielonka TM. The role of ANCA and anti-GBM antibodies in pulmonary-renal syndrome due to Wegener's Granulomatosis. J Physiol Pharmacol 2007; 58 (Suppl. 5): 839-846.
3. Sigumoto T, Deji N, Kume S et al. Pulmonary-renal syndrome, diffuse pulmonary hemorrhage and glomerulonephritis, associated with Wegener's granulomatosis effectively treated with early plasma exchange therapy. Intern Med 2007; 46: 49-53.
4. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener's granulomatosis: A clinical and imaging study of 77 cases. Chest 1990; 97: 906-912.
5. Weir IH, Muller NL, Chiles C et al. Wegener's granulomatosis: findings from computed tomography of the chest in 10 patients. Can Assoc Radiol J 1992; 43: 31-34.
6. Maskell GF, Lockwood CM, Flower CDR. Computed tomography of the lung in Wegener's granulomatosis. Clin Radiol 1993; 48: 377-380.
7. El-Zammer OA, Katzenstein AL. Pathological diagnosis of granulomatous lung disease: a review. Histopatology2007; 50: 289-310.
8. Reuter M, Schnabel A, Wesner F. Pulmonary Wegener's granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity. Chest 1998; 114: 500-506.
9. Sheehan RE, Flint JDA, Muller NL. Computed tomography features of the thoracic manifestations of Wegener Granulomatosis. J Thorac Imaging 2003; 18: 34-41.
10. Brillet PY, Brauner M. Pulmonary imaging in ANCA-associated vasculitides. Presse Med 2007; 36: 907-912.
11. Pesci A, Manganelli P. Respiratory system involvement in ANCA-associated systemic vasculitides: clinical, pathological, radiological and therapeutical considerations. Drugs 2007; 8: 25-42.
12. Hanak V, Golbin JM, Hartman TE et al. High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hipersensitivity pneumonitis. Chest 2008; 134: 133-138.
13. Goh NS, Desai SR, Veeraraghavan S et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177: 1248-1254